FDM IMMO
Board
1 director, last change in 2022Director (not named in the articles)
appointed by deed of 18-02-2021
term without a fixed end
listed in the 2025 annual accounts, filed on 31-07-2026
Mandates through the years
2 names, the dashed line is todayDE MUNCK François
Director
Director
DELTOUR Josette Jean Orphine
Statutory manager
Statutory manager
BoardEarliermandate already running before its first mention
Mandates as a list
- DE MUNCK François
- Director, appointed by deed of 18-02-2021, still in office
- DELTOUR Josette Jean Orphine
- Statutory manager, until 19-04-2022
Control
Parent
Equity €1.8m
Profit €357,146 in 2025 (profit €308,750 in 2024)
Checked score 97
Source: accounts FDM PHARMA 2025
100%
This company
FDM IMMO
Equity €660,562
Loss €22,600 in 2025
Capital
- Contribution
- €14,260
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- FDM PHARMA
Source: lists of holdings in the owners' accounts
Articles of association
deed of 19-04-2022 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant,moitié acquéreurs au prorata, mêmes formalités si non actionnaires de plein droit”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 10:00
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 18-02-2021 ↗
- FDM Pharma srl (BE 0546.573.521) 200 shares
Capital over time
- 19-04-2022 Converted to unavailable equity